Treace Medical Concepts, Inc. (TMCI)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 87
-0.25
-6.068%
$
256.25M Market Cap
- P/E Ratio
- Div Yield
131,600 Volume
-0.93 Eps
$ 4.12
Previous Close Investors:
Want to track TMCI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Treace Medical Concepts, Inc. (TMCI) Statistics
Valuation metrics
Market Cap 256.25M
Enterprise value 311.76M
Trailing P/E (ttm) -4.16
Forward P/E -
PEG ratio 0.23
Price/Sales (ttm) 1.23
Price/Book (mrq) 3.72
Enterprise Value/Revenue 1.52
Enterprise Value/EBITDA -6.89
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 186.96K
Average volume (90 days) 298.08K
Price summary
52-Week low 1.17
52-Week high 7.08
Beta -
50-Day moving average 4.41
200-Day moving average 3.65
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.29%
Operating margin -0.26%
Operational effectiveness
Return on assets -0.33%
Return on equity -0.74%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.16
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.91
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.7
Total debt (mrq) -
Total Debt/Equity (mrq) 1.07
Current ratio (mrq) 2.9%
Book value per share (mrq) 1.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
